Integrated Nanotherapeutics Inc.

In addition, we are advancing a therapeutic platform that induces antigen-specific tolerance to treat autoimmune diseases. We are determined to develop innovative drug delivery systems that enable the full therapeutic potential of various compounds as safe and effective nanomedicines. Integrated Nanotherapeutics (INT) is a biotech company in Vancouver, Canada focused on using nanotechnology to uncover and maximize the therapeutic potential of many drugs. Our proprietary drug delivery platform technology can deliver any type of drug modality in lipid nanoparticles (LNPs), either alone or in combination, to disease tissues and cells. Integrated Nanotherapeutics is founded by a team of world-class scientists with multi-disciplinary skills in basic science, preclinical research, drug development, and commercialization of therapeutics. We have collectively over 100 years of experience in lipid nanoparticle (LNP) science and drug development. We strive to become the leading nanomedicines company in the world and provide advanced, first-in-class therapies to many people. Our versatile drug delivery platform allows the incorporation of virtually any small molecule and/or biologic into lipid nanoparticles (LNPs).